May 5, 2008 - The research for non-invasive glucose monitoring has found new investors: The Zürich Cantonal Bank will invest in Solianis; together with a research grant from the European Union and private investors a total of CHF 2.5 Mio is raised......"With this capital increase we can continue the current clinical work to demonstrate that our technology is applicable in the daily life of patients". Solianis Monitoring AG is developing a device for the non-invasive monitoring of blood glucose for patients with diabetes to improve their quality of life... [PDF] Solianis Monitoring's Press Release -
